OBJECTIVES: To report preliminary results from a modified pubovaginal sling procedure using @entity7502 mesh as the sling suspended by nonabsorbable sutures anchored to the pubic tubercle with Vesica bone anchors. METHODS: Thirty-five @entity1 with @entity3142 (SUI) (with or without associated @entity6369 ) or type II SUI with additional risk factors such as @entity28 , @entity1030 , or failed prior incontinence-correcting procedures underwent this modified pubovaginal sling procedure. Postoperative voiding status was evaluated during office follow-up visits and telephone surveys. RESULTS: With a mean follow-up of 8.4 months (range 2 to 18), 32 @entity1 (91.4%) were dry, 1 improved, and 2 remained incontinent. The pubovaginal sling procedure was the only operation performed in 46% of @entity1 , with a mean operative time of 72 minutes, a mean estimated @entity190 of 137 mL, and a mean hospital period of 2.3 days. @entity1 on whom concomitant gynecologic procedures were performed had a mean duration of surgery of 122 minutes, a mean estimated @entity190 of 202 mL, and a mean hospitalization period of 2.9 days. Thirteen @entity1 had preoperative urgency that persisted in 31% of @entity1 . De novo urgency developed in 3 @entity1 . Seven @entity1 required prolonged suprapubic tube drainage but no @entity1 remained in permanent retention. There has been no @entity281 . CONCLUSIONS: Our experience with this modified pubovaginal sling procedure using @entity7502 mesh and Vesica bone anchors showed excellent results with greater technical ease, minimal morbidity, and decreased hospitalization period when compared to a traditional pubovaginal sling performed in our hands. Additional follow-up will be needed to assess long-term efficacy.

Pubovaginal sling using XXXX mesh and Vesica bone anchors.

@entity1 :: ('9606', 'Species') :: ['women', 'Patients', 'patients', 'patient'] @entity6369 :: ('MESH:D014526', 'Disease') :: ['urethral hypermobility'] @entity28 :: ('MESH:D009765', 'Disease') :: ['obesity'] @entity190 :: ('MESH:D006473', 'Disease') :: ['blood loss'] @entity7502 :: ('MESH:D011126', 'Chemical') :: ['polypropylene'] @entity281 :: ('MESH:D007239', 'Disease') :: ['infection or erosion'] @entity1030 :: ('MESH:D029424', 'Disease') :: ['chronic obstructive pulmonary disease'] @entity3142 :: ('MESH:D014550', 'Disease') :: ['type III stress urinary incontinence']
@entity7502 :: (MESH:D011126,Chemical) :: ['polypropylene']
